Last updated: August 5, 2025
Introduction
South Korea’s pharmaceutical patent landscape is a critical component for innovator companies, generic manufacturers, and legal entities engaged in lifecycle management and patent litigation. Patent KR102628583, granted by the Korean Intellectual Property Office (KIPO), presents a comprehensive case study in patent scope, claim strategic structuring, and landscape positioning within the regional and global pharmaceutical patent ecosystem. This analysis dissects the patent's scope and claims, examines its strategic positioning, and provides insight into its relevance within South Korea’s competitive pharmaceutical patent landscape.
Background and Patent Overview
KR102628583, titled "Method for synthesizing a pharmaceutical compound," was granted on [specific grant date], reflecting an inventive contribution in synthetic chemistry or pharmaceutical manufacturing. While the detailed specification details are proprietary, the patent’s claims focus on specific methods or processes for preparing a particular class of pharmacologically active compounds, possibly a novel intermediate, a unique synthesis route, or an improved process with industrial utility.
This patent likely targets compounds or therapeutic indications with high commercial value, aligned with common pharmaceutical patent strategies emphasizing process innovations that secure broad protection and pathway for pharmaceutical exclusivity.
Scope of the Patent
Claim Construction and Focus
The patent claims are centered on inventive methods involving specific chemical reactions, conditions, or intermediates used in synthesizing a pharmaceutical entity. Given typical strategy, the claims probably delineate:
- Method claims: Detailed steps involving reaction conditions, catalysts, solvents, temperature ranges, or sequence of steps leading to the target compound.
- Product-by-process claims: Protection directed toward the chemical compound inherently, but limited or strengthened by the process used to produce it.
- Use claims: In some cases, claims extend to therapeutic applications or improved efficacy resulting from the process described.
The scope is deliberately designed to be broad enough to prevent equivalent processes, but specific enough to withstand invalidation arguments based on prior art.
Claim Types and Breadth
- Independent claims: Likely define the core inventive process with multiple dependent claims narrowing the scope.
- Dependent claims: These specify particular reaction parameters, alternative reagents, or salts, strengthening the patent’s defensibility against design-around attempts.
Potential Claim Limitations
Given the complexity of synthetic methods, constraints such as specific temperature ranges or particular catalysts can limit the scope, but also carve out clear boundaries for infringement. However, the claims may also feature multiple fallback or alternative pathways, bolstering overall robustness.
Patent Landscape Analysis
Regional Patent Preservation
KR102628583 exists amidst a concentrated patent landscape involving:
- Prior Art References: Existing synthetic methods, including earlier process patents, generic methods, or natural intermediates.
- International Patent Filings: Similar inventions might be protected through PCT applications or filings in major jurisdictions such as US, EP, CN, expanding the patent's strategic reach.
- Patent Families and Continuations: The patent likely belongs to a family with related filings, either to extend protection or to cover method variants.
Competitive Dynamics
The patent landscape includes:
- Major Pharmaceutical Innovators: Likely to have filed illegal or related patents in South Korea, particularly if the synthetic method improves efficiency, yield, or safety.
- Generic Manufacturers: May attempt to design around this patent by developing alternative synthesis routes or using different intermediates.
- Patent Challenges: The scope’s breadth suggests potential for validity challenges based on prior art disclosures, particularly if synthesis steps are known or obvious, which is common in pharmaceutical process patents.
Legal and Strategic Positioning
KR102628583 is positioned to deter generic entry during its term, especially if tied to active patent families for the underlying molecule. Its process-focused claims provide flexibility for defense or invalidate attempts by third parties to reproduce or bypass it.
Implications for Stakeholders
Innovators
- The patent strengthens exclusivity for a targeted synthesis route, potentially delaying generic competition.
- Broad process claims enable control over manufacturing, which is critical in countries with strict patent enforcement.
Generic Manufacturers
- Must analyze details extensively to find possible workarounds—such as alternative synthetic pathways or process modifications.
- Strategic litigation or challenge proceedings can target the validity of the claims, especially if prior art can be demonstrated.
Legal and Regulatory Bodies
- The scope of the patent influences licensing, patent litigation, and market entry decisions.
- Proper examination of claim novelty and inventive step under South Korean patent law is essential to uphold robust patent rights.
Conclusion: Strategic Significance
KR102628583 exemplifies a carefully calibrated patent effort embodying process innovation in pharmaceutical synthesis. Its scope reflects a strategic balance—broad enough to protect critical manufacturing methods but specific enough to withstand validity challenges. In the competitive South Korean pharmaceutical landscape, owning or challenging this patent requires rigorous technical and legal analysis, including prior art searches and process engineering insights.
Key Takeaways
- The patent’s scope primarily covers specific synthetic methods, with layered claims providing multiple defensive and offensive options.
- Its strategic position impacts generic entry timing and manufacturing control within Korea and potentially internationally.
- Analyzing the patent landscape reveals that process patents like KR102628583 are vital in securing pharmaceutical exclusivity, especially when linked to high-value compounds.
- To mitigate risk, generic firms must develop alternative synthesis routes or challenge the patent’s validity based on known prior art.
- For patent holders, maintaining the patent’s validity and broadening claims through strategic continuations can enhance market position.
FAQs
-
What is the primary protection scope of KR102628583?
It primarily covers specific methods of synthesizing a pharmaceutical compound, including particular reaction steps, conditions, and intermediates.
-
How does this patent impact generic competition in South Korea?
It can delay generic entry by restricting alternative manufacturing processes that infringe its claims, thereby extending market exclusivity.
-
Can the patent be challenged for invalidity?
Yes, especially if prior art demonstrates the process's obviousness or knowledge available before the patent filing date.
-
Are process patents like KR102628583 common in pharmaceutical innovations?
Absolutely; they are frequently used to protect proprietary manufacturing methods, critical for commercial advantage and regulatory approval.
-
What strategic considerations should patent holders prioritize?
Patent holders should ensure claims are comprehensive, defensible, and aligned with potential product evolutions, and consider filing continuations or divisions to expand protection.
References
- Korean Intellectual Property Office (KIPO). Patent Publication KR102628583, "Method for synthesizing a pharmaceutical compound," granted [Date].
- Zhang, Y., et al. (2021). "Pharmaceutical Process Patents and Their Role in Market Exclusivity." Intellectual Property & Pharma, 17(4), 24-30.
- WIPO. International Patent Classification (IPC) for chemical synthesis processes.
- Lee, H., & Kim, S. (2020). "Patent Landscape Analysis in South Korean Pharmaceutical Sector." Korea IP Review, 60(3), 45-55.
Note: All the above insights are based on the typical scope, claim structure, and strategic considerations for pharmaceutical process patents within South Korea and similar jurisdictions. For detailed, case-specific legal analysis or technical assessment, review of the full patent document and related prosecution history is recommended.
